The Drug-Induced Respiratory Disease Website and App
Frequency - Incidence
Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases
Evidence level/grade
Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic
Mycobacterium bovis/BCG infection
Risk increases in naturally or iatrogenically immunosuppressed individuals (PMID 12856232). Can be fatal
Publications
Saldaña NG, Ranero ARC, Trujillo DMG, Garza EA, Tortoriello AIQ, Ruiz BV, Jurado RR, Olguín HJ, Silva ML
Osteitis secondary to BCG vaccine in immunocompetent patients: Three case reports.
Medicine 2019 Jan;98;e13871 — 2019 Jan — e13871
Rermruay R, Rungmaitree S, Chatpornvorarux S, Brukesawan C, Wittawatmongkol O, Lapphra K, Phongsamart W, Kongstan N, Khumcha B, Chokephaibulkit K
Clinical features and outcomes of Bacille Calmette-Guérin (BCG)-induced diseases following neonatal BCG Tokyo-172 strain immunization.
Vaccine 2018 06 27;36;4046-4053 — 2018 06 27 — 4046-4053
A Cohort of 169 Chronic Granulomatous Disease Patients Exposed to BCG Vaccination: a Retrospective Study from a Single Center in Shanghai, China (2004-2017).
Journal of clinical immunology 2018 04;38;260-272 — 2018 04 — 260-272
Sellami K, Amouri M, Kmiha S, Bahloul E, Aloulou H, Sfaihi L, Guirat R, Mseddi M, Kamoun T, Hachicha M, Turki H
Adverse Reactions Due to the Bacillus Calmette-Guerin Vaccine: Twenty Tunisian Cases.
Indian journal of dermatology 2018 Jan-Feb;63;62-65 — 2018 Jan-Feb — 62-65
Clinical and laboratory observation of Bacillus Calmette-Guérin infections.
International journal of clinical and experimental medicine 2015;8;10099-104 — 2015 — 10099-104